MRNA - Moderna reaffirms Phase 3 win for next-gen COVID shot
2024-06-13 07:26:13 ET
More on Moderna
- Moderna, Inc. (MRNA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Moderna, Inc. (MRNA) Jefferies 2024 Global Healthcare Conference (Transcript)
- Moderna, Inc. (MRNA) Moderna Oncology Investor Event (Transcript)
- Moderna’s COVID/flu combo vaccine succeeds in late-stage trial
- FDA selects JN.1 variant for next COVID vaccine campaign